Zoetis | ZTS - Net Income

Stock Price
126.73
Daily Change
4.32 3.53%
Monthly
-2.04%
Yearly
-27.86%
Q1 Forecast
120.98

Zoetis reported $721M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
Bayer EUR -963M 764M Sep/2025
Bristol-Myers Squibb USD 2.2B 891M Sep/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Dentsply International USD -427M 382M Sep/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Henry Schein USD 101M 15M Sep/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Illumina USD 150M 85M Sep/2025
IQVIA Holdings USD 331M 65M Sep/2025
J&J USD 5.12B 36M Dec/2025
Laboratory Of America USD 261.1M 23.2M Sep/2025
Merck USD 2.96B 2.82B Dec/2025
Neogen USD -15.92M 52.26M Sep/2025
Pacira USD 5.43M 10.28M Sep/2025
Perrigo USD 7.5M 15.9M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Quest Diagnostics USD 245M 37M Sep/2025
Sanofi EUR -801M 3.6B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Zoetis USD 721M 3M Sep/2025